Gpt Healthcare Limited · NSE:GPTHEALTH
Gpt Healthcare — Q1 FY2027 Earnings Presentation
32 slides from Gpt Healthcare's earnings presentation, Aug 3, 2026
Slide 1: Submission of Investor Presentation to Stock Exchanges
GPT Healthcare Limited Regd. Office: GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106, India CIN : L70101WB1989PLC047402 Phone : +91-33-4050-7000, Email : info@gptgroup.co.in , Visit us: www.gptgroup.co.in GPTHEALTH/CS/SE/2026-27 August 3, 2026 The Department of Corporate Services Nationa
Slide 2: GPT Healthcare Limited Investor Presentation Q1FY27
GPT HEALTHCARE LIMITED Investor Presentation Q1FY27
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by GPT Healthcare Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any secur
Slide 4: Key Highlights of the Q1FY27
Key Highlights of the Q1FY27 Operational performance remained healthy, with ARPOB increasing to ₹42350 driven by an improved clinical mix and operating efficiencies. Network occupancy stood at 45.5% (excluding Raipur: 58.07%), while mature hospitals continued to deliver resilient performance support
Slide 5: Company Overview
Company Overview GPT Healthcare Limited is a fast-growing hospital platform in Eastern India, operating five, neighborhood tertiary-care hospitals located within densely populated residential areas. 719 115 Designed around a proximity-based model, its hospitals offer Beds- total capacity Full time c
Slide 6: Financial Snapshot
a S ° bo Financial Snapshot
Slide 7: Financial Snapshot for Q1 FY27
Financial Snapshot for Q1 FY27 Q1 FY27 Revenue from Operations EBITDA & EBITDA Margin PAT & PAT Margin Rs 126.2 Cr Rs 26.2 Cr Rs 12.7 Cr (Overall – 20.4% Margin, (9.9 % Margin) Raipur – Rs 10.6 Cr, Mature – Rs 115.6 Cr 38.5% YoY) 17.8% YoY 65.7% YoY ARPOB Occupancy Rate % Dum Dum Rs 42,350 45.5 % Ra
Slide 8: Hospital-wise performance for Q1 FY27
Hospital-wise performance for Q1 FY27 Salt lake Hospital Agartala Hospital Dum-Dum Hospital Howrah Hospital Raipur Hospital West Bengal Tripura West Bengal West Bengal Chhattisgarh Year of 2000 2011 2013 2019 2025 commissioning Q1FY27 Q1FY27 Q1FY27 Q1FY27 Q1FY27 Bed capacity 85 205 155 116 158 (No o
Slide 9: Hospital Portfolio
a S ° bo Hospital Portfolio
Slide 10: ILS Salt Lake Hospital
ILS Salt Lake Hospital 85-bed tertiary surgical hospital with 17 ICUs and 3 OTs, scaled from an 8-bed facility. Clinical focus on robotic gastro and bariatric surgeries, enabling higher case 85 17 & 3 complexity. Total Number of beds ICU & OTS Specialised care offerings including diabetic foot care
Slide 11: ILS Agartala Hospital
ILS Agartala Hospital 205-bed ,corporate hospital with 66 ICUs, 8 OTs and 1 cath lab, offering large- scale critical care capacity Clinical leadership in the state, with multiple first-in-Tripura procedures 66,8 &1 including leadless dual chamber implantation and complex vascular stenting ICU,OTS &
Slide 12: ILS Dum Dum Hospital
ILS Dum Dum Hospital 155-bed, six-storey tertiary facility with strong focus on multispecialty and critical care delivery Licensed for renal transplants with upgraded gastroenterology services, 155 53, 4 &1 forming the core specialty base Total Number of beds ICU,OTS & Cath Labs Known for renal and
Slide 13: ILS Howrah Hospital
ILS Howrah Hospital 116 Bed, Multi-specialty tertiary care hospital in Howrah, located near Railway Station, with no competing hospital within a 5-km radius Launched robot-assisted orthopaedic surgery, including robotic knee 116 43,3 &1 replacements. Total Number of beds ICU,OTS & Cath Labs Emergenc
Slide 14: ILS Raipur Hospital
ILS Raipur Hospital 158 Bed ,Quaternary care hospital commencing its operations from May 2025, at Pachpedi Naka, serving a large catchment across Raipur, Bilaspur, Durg and Bhilai The Renal transplant program is commenced and chemotherapy & oncology surgeries fully operational 158 5&1 Progressive ex
Slide 15: Our cutting-edge investments
Our cutting-edge investments MAKO – Orthopedic robot for joint Robotic assisted GI Surgery 3 Tesla MRI and Cath Lab Facilities replacement Well- equipped ICU’s and NICU’s Radiation and oncology State-of-the-art Operation theatres 14
Slide 16: Technology-Enabled Healthcare Innovation
Technology-Enabled Healthcare Innovation SPARSH – Healthcare ILS-My Health app HMIS enhancing Advancing healthcare at home for senior enhancing patient efficiency and through cutting edge citizens convenience patient care technology A home healthcare service for senior Hospital Management Informatio
Slide 17: Emerging Markets, Proposition & Path Ahead
Emerging Markets, Proposition & Path Ahead
Slide 18: Emerging Opportunities in Industry (1/2)
Emerging Opportunities in Industry (1/2) High – Multiple Growth expected Medical Tourism growth corridor Eastern India is emerging as a hub for international patients Attractive 20x–30x EBITDA valuations amid strong growth in from Bangladesh, Nepal, Bhutan with its market expected to India’s healthc
Slide 19: Emerging Opportunities in Industry (2/2)
Emerging Opportunities in Industry (2/2) Global Health-care demand Work Force shortage Persistent shortages of doctors and nurses are accelerating The global healthcare market is projected to reach $ 665.37 the shift toward organized healthcare platforms that can billion by 2028. attract talent, sta
Slide 20: Key Investment Proposition
Key Investment Proposition Eastern India Expand in Eastern India by leveraging strong regional brand Market Leadership equity and capitalizing on rising healthcare demand. Strategic Leverage strategic locations in dense residential area near Positioning transport hubs to create easy patient access.
Slide 21: Path Ahead
Path Ahead Next-Gen Care Asset-Light Quality- Led Returns Delivery Expansion Unlocking Operating Rapid Capacity Balanced leverage Robotic surgery Expansion Maintain long term specialty mix Rapid scale-up with integrated ROE and ROCE ~ 25% low capital intensity as part of a alongside ongoing through
Slide 22: Short-term Outlook
Short- term Outlook Strategic Expansion Outlook • Jamshedpur Hospital: MoU signed for a 155-bed facility with INR 75 crore investment, targeted commissioning by end-FY27. • Planned entry into Tier II cities (Uttar Pradesh, Assam, Odisha) and select Tier I locations in Eastern India. • Land and build
Slide 23: Financial & Operational Highlights
Financial & Operational Highlights
Slide 24: Key financial metrics for Q1 FY27
Key financial metrics for Q1 FY27 Revenue from Operations (INR Cr) EBITDA (INR Cr) & EBITDA Margin (%) PAT (INR Cr) & PAT Margin (%) 23.0% 22.1% 18.8% 21.6% 20.4% 11.9% 12.0% 8.8% 12.4% 9.9% 478 93 50 92 90 48 400 407 42 107 126 26 13 19 8 FY24 FY25 FY26 Q1FY26 Q1FY27 FY24 FY25 FY26 Q1FY26 Q1FY27 FY
Slide 25: Key operational metrics for Q1 FY27
Key operational metrics for Q1 FY27 No of Beds & Occupancy Rate (%) Average length of stay (days) Average Revenue per Occupied Bed (INR) 56.4% 58.9% 58.9% 53.1% 45.5% 3.95 719 719 719 4.0 3.54 3.50 3.48 42,350 3.35 39,243 3.5 37,180 38,913 561 561 3.0 32,947 2.5 2.0 1.5 1.0 0.5 0.0 FY24 FY25 FY26 Q1
Slide 26: Revenue distribution of care services across hospitals
Revenue distribution of care services across hospitals (Input required) FY25 FY26 Q1FY27 1% 12% 13% 4% 19% 18% 3% 9% 25% 3% 4% 7% 8% 13% 5% 16% 20% 9% 19% 11% 8% 5% 8% 10% 16% 10% 4% 11% 5% 5% 4% 5% 4% 5% Internal Medicine & Diabetology Critical Care Gynaecology and obstetrics Neurosciences Nephrolo
Slide 27: Profit and Loss Highlights – Q1 FY27
Profit and Loss Highlights – Q1 FY27 Particulars Q1 FY27 Q1 FY26 Y-o-Y Q4 FY26 Q-o-Q FY26 Revenue from Operations 126.2 107.1 126.4 472.5 Other Operating Income 2.0 1.6 1.6 6.0 Total Revenue 128.2 108.7 18.0% 128.0 0.2% 478.5 Cost of Material Consumed 24.1 20.7 23.4 89.8 Employee Benefits Expenses 2
Slide 28: Historical Profit and Loss Statement
Historical Profit and Loss Statement Particulars FY24 FY25 FY26 Revenue from Operations 400.2 407.1 472.5 Other Operating Income 5.3 8.5 6.0 Total Revenue 405.7 415.6 478.5 Cost of Material Consumed 83.0 78.8 89.8 Employee Benefits Expenses 68.9 73.0 84.4 Other Expenses 160.5 171.9 214.2 EBITDA 93.1
Slide 29: Professional and Experienced Leadership – Board of Directors
Professional and Experienced Leadership –Board of Directors Dr. Om Tantia Shree Gopal Tantia Anurag Tantia Dr. Aruna Tantia Dr. Ghanshyam Goyal Chairman & Managing Director Vice Chairman Executive Director Non - Executive Director Non - Executive Director • Founding member of ILS Hospitals • More th
Slide 30: Awards & Accreditations
Awards & Accreditations Great place to Leading chain of The Eastern India work Award multispecialty award Best Health care brand Best Employer Brand Awards NABH Nursing Excellence The Happening awards Eastern India Quality Brand of Certification Bengal Brilliance Leadership Awards India Award 29
Slide 31: Stock Information
Stock Information Share Price Movement Shareholding Pattern (Jun’26) 200 180 24.5% 160 140 6.9% 120 3.0% 65.6% Price in Rs 100 80 Promoters FII DII Public 60 Stock Data (As on 30thJul, 2026) 40 BSE/NSE Code 544131 | GPTHEALTH 20 CMP (Rs) 163.94 0 Market Cap (Rs Cr) 1137.82 25-Jun-26 06-Nov-25 13-Feb
Slide 32: Thank You
COMPANY : GPT HEALTHCARE LIMITED CIN : L70101WB1989PLC047402 www.ilshospitals.com INVESTOR RELATIONS ADVISORS : MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services Ms. Sejal Bhattar Sejal.bhattar@in.mpms.mufg.com Sejal.bhattar@in.mpms.mufg